| Literature DB >> 35399732 |
Hafiz Muhammad Ishaq1,2, Imran Shair Mohammad3,4, Riaz Hussain5, Rashida Parveen6, Jafir Hussain Shirazi7, Yang Fan8, Muhammad Shahzad9, Khezar Hayat10, Huan Li11, Ayesha Ihsan12, Kiran Sher Muhammad13, Muhammad Usman2,12, Siruo Zhang1, Lu Yuan1, Shakir Ullah1, Ana Cláudia Paiva-Santos14,15, Jiru Xu1.
Abstract
Thyroid cancer in humans has a fast-growing prevalence, with the most common lethal endocrine malignancy for unknown reasons. The current study was aimed to perform qualitative and quantitative investigation and characterization of the gut bacterial composition of euthyroid thyroid cancer patients. The fecal samples were collected from sixteen euthyroid thyroid cancer patients and ten from healthy subjects. The PCR-DGGE was conducted by targetting the V3 region of 16S rRNA gene, as well as real-time PCR for Bacteroides vulgatus, E.coli Bifidobacterium, Clostridium leptum and Lactobacillus were carried. High-throughput sequencing of V3+V4 region of 16S rRNA gene was performed on Hiseq 2500 platform on 20 (10 healthy & 10 diseased subjects) randomly selected fecal samples. The richness indices and comparative diversity analysis showed significant gut microbial modification in euthyroid thyroid cancer than control. At phylum level, there was significant enrichment of Firmicutes, Verrucomicrobia, while a significant decrease in Bacteroidetes was detected in the experimental group. At family statistics, significant high levels of Ruminococcaceae and Verrucomicrobiaceae, while the significant lower abundance of Bacteroidaceae, Prevotellaceae, Porphyromonadaceae, and Alcaligenaceae was after observed. It also found that the significantly raised level of Escherichia-Shigella, Akkermansia [Eubacterium]_coprostanoligenes, Dorea, Subdoligranulum, and Ruminococcus_2 genera, while significantly lowered genera of the patient group were Prevotella_9, Bacteroides and Klebsiella. The species-level gut microbial composition showed a significantly raised level of Escherichia coli in euthyroid thyroid cancer. Thus, this study reveals that euthyroid thyroid cancer patients have significant gut microbial dysbiosis. Moreover, Statistics (P<0.05) of each gut microbial taxa were significantly changed in euthyroid thyroid cancer patients. Therefore, the current study may propose new approaches to understanding thyroid cancer patients' disease pathways, mechanisms, and treatment. © The author(s).Entities:
Keywords: Characterization; DGGE; Euthyroid thyroid cancer; Gut microbiota.; High-throughput sequencing
Year: 2022 PMID: 35399732 PMCID: PMC8990431 DOI: 10.7150/jca.66816
Source DB: PubMed Journal: J Cancer ISSN: 1837-9664 Impact factor: 4.207
Scheme 1The whole study methodology and results clearly indicate gut bacterial dysbiosis in euthyroid thyroid cancer patients.
Primers used in Real-time PCR and PCR-DGGE
| Target bacteria | Primer Sequence (5¹-3¹) | |
|---|---|---|
| PCR-DGGE Primer | ||
| 341-F | CCTACGGGAGGCAGCAG | |
| 534-R | ATT ACCGCGGCTGCTGG | |
| 341FG | CGCCCGCCGCGCGCGGCGGCGCGGGGCGGGGGCACGGGGGGCCTACGGGAGGCAGCAG | |
| Real-Time PCR Primer | ||
| Bifid F | CTC CTGGAAACGGGTGG | |
| Bifi-R | GGTGTTCTTCCCGATATCTACA | |
| Lact F | CTCAAAACTAAACAAAGTTTC | |
| Lact R | CTCAAAACT AAACAAAGTTTC | |
| BV- F | GCATCATGAGTCCGCATGTTC | |
| BV-R | TCCATACCCGACTTTATTCCTT | |
| Escherichia coli (287bp) | CATTGACGTTACCGCAGAAGAAGC | |
| CTCTACGAGACTCAAGCTTGC | ||
| C.lep-F | GCACAAGCAGTGGAGT | |
| C.lep-R | CTTCCTCCGTTTTGTCAA | |
Figure 1(A) Assembling the DGGE profile of euthyroid thyroid cancer patients (D1-D8) and control subjects (C1-C5). (B) UPGMA application for Cluster analysis between diseased (D1-D8) and controlled (C1-C5) groups. (C) DGGE depicts constructed between euthyroid thyroid cancer (D9 -D16) and control groups (C6-C10). (D) assembly analysis of euthyroid thyroid cancer(D9 -D16) and control (C6-C10) groups by applying UPGMA.“a” and “b” in figure (A) and (C) constitute the dominant bands of different patients. D or C represents the euthyroid thyroid cancer patients and control subjects, respectively.
Gut microbial similarity and diversity of euthyroid thyroid cancer patients and healthy group
| Groups | Diversity | Similarity | ||
|---|---|---|---|---|
| The number of Bands | Shannon Index | Intra-similarity | Inter-similarity | |
| Disease group | 14.1 ± 3.21 | 3.225 ± 0.422 | 0.319 ± 0.141 | 0.269 ± 0.125 |
| Control group | 8.6 ± 2.55 | 2.542 ± 0.432 | 0.288 ± 0.130 | |
| P. Value | 0.001 | 0.003 | / | / |
Significantly different results (unpaired t-test), with P<0.05
a. DGGE bands number produced by each sample.
b. Shannon diversity index (H¹) was calculated with the help of all DGGE bands ( relative intensities) in each sample.
c. Comparing DGGE band profiles with Dice similarity coefficients within the individual of a given group.
d. Comparing DGGE band profiles with Dice similarity coefficients between members of euthyroid thyroid cancer and the healthy group.
Sequencing of re-amplified PCR Amplicons excised bands from DGGE gel and identities were checked by BLAST database.
| Selected Excised bands | Bacteria with the highest % homology | Sequence Accession number | Bacterial phyla | Gene bank number |
|---|---|---|---|---|
| D3a | Escherichia coli (93). | IAI39. | Proteobacteria | NZ_JH114216.1 |
| D3b | Proteus mirabilis (94). | HI4320. | Proteobacteria | NC_010554.1 |
| D3c | Pseudomonas cremoricolorata (98). | ND07. | Proteobacteria | NZ_CP009455.1 |
| D3d | Prevotella oulorum (93). | F0390. | Bacteroidetes | NZ_JH114216.1 |
| D5a | Prevotella copri( 96). | DSM 18205. | Bacteroidetes | NZ_GG703862.1 |
| D5b | Faecalibacterium prausnitzii (96). | TDY5834930. | Firmicutes | NZ_CZBH01000014.1 |
| D6a | Phascolarctobacterium sp (94). | YIT 12067. | Firmicutes | NZ_GL830850.1 |
| D7a | Alistipes putredinis (99). | DSM 17216. | Bacteroidetes | NZ_DS499580.1 |
| C2a | Bacteroides oleiciplenus (92). | YIT 12058. | Bacteroidetes | NZ_JH992946.1 |
| C3a | Bacteroides uniformis (90). | CL03T00C23. | Bacteroidetes | NZ_JH724260.1 |
| C4a | Barnesiella intestinihominis (98). | YIT 11860. | Bacteroidetes | NZ_JH815205.1 |
| C5a | Prevotella copri (96). | DSM 18205. | Bacteroidetes | NZ_GG703862.1 |
| C5b | Bacteroides stercoris (90). | ATCC 43183. | Bacteroidetes | NZ_DS499675 |
| D10a | Shigella dysenteriae (98). | Sd197. | Proteobacteria | NC_007606.1 |
| D10b | Bacteroides pyogenes (88). | JCM 10003. | Bacteroidetes | NZ_BAIU01000058.1 |
| D10c | Bacillus sp. (94). | FJAT-25496. | Firmicutes | NZ_LMBY01000086.1 |
| D15a | Klebsiella sp.(94). | NODE14. | Proteobacteria | NZ_LGIT01000014.1 |
| D15b | Enterobacter sacchari (94). | SP1. | Proteobacteria | NZ_CP007215.2 |
| D16a | Parabacteroides distasonis (97). | ATCC 8503 | Bacteroidetes | NZ_JH815205.1 |
| D16b | Bacteroides vulgatus ( 98). | ATCC 8482. | Bacteroidetes | NC_009614.1 |
| C6a | Bacteroides vulgatus ( 98). | ATCC 8482. | Bacteroidetes | NC_009614.1 |
| C10a | Bacteroides paurosaccharolyticus (91). | JCM 15092. | Bacteroidetes | NZ_BAJR01000054.1 |
Real-time PCR quantification results in different gut bacteria
| Bacteria | Healthy Subjects | Patients | P value |
|---|---|---|---|
| Bifidobacterium (104) | 6.73±0.87 | 6.30±0.90 | 0.123 |
| Bacteroides vulgatus(109) | 6.59±0.82 | 5.77±0.86 | 0.011 |
| Lactobacillus (105) | 6.98±0.99 | 6.19±0.98 | 0.029 |
| Clostridium leptum (107) | 3.75±1.11 | 4.05±1.07 | 0.249 |
| Escherichia coli (106) | 4.89±0.74 | 5.60±0.78 | 0.016 |
Results were presented as the average estimate of logarithms of fecal PCR target genetic amplicon copy numbers present in 1 g of feces, where (P < 0.05).
Figure 2Euthyroid thyroid cancer observation of Tag number and OTUs analysis with comparison of control, Tag number and OTUs were estimated at the level of (97 %) similarity
Gut bacterial richness and diversity index, based on 97% similarity through High-throughput analysis.
| Group | Observed Species | OTUs | Shannon | Simpson | Chao1 | ACE | PD Tree | Evenness |
|---|---|---|---|---|---|---|---|---|
| Patients | 255 | 248 | 4.62 | 0.876 | 273.50 | 279.39 | 22.02 | 0.357 |
| Control | 226.5 | 273.2 | 3.85 | 0.770 | 240.24 | 244.54 | 19.44 | 0.296 |
| P. Value | 0.042 | 0.067 | 0.011 | 0.0321 | 0.036 | 0.030 | 0.037 | 0.014 |
Figure 3Diversification among euthyroid thyroid cancer samples of High-throughput sequencing. UPGMA is based on weighted UniFrac distances. D and C denotes the euthyroid thyroid cancer patients and controlled group, respectively.
Figures 4(A) Beta diversity between diseased and healthy subjects. PCA plots which are obtained from Highthrough-put sequencing of fecal microbial DNA samples. (B) NMDS plot between study and control bacterial DNA samples. Each dot in the plot indicates an individual fecal bacterial DNA Samples of patient and control group
Figure 5(A) Configuration of Gut microbiota at phyla levels from High-throughput sequencing results. The excessive occurrence of the most prevalent phyla in euthyroid thyroid cancer and control D and C designated as euthyroid thyroid cancer patients and control group, respectively, (B) High-throughput sequencing findings of gut bacterial conformation at family level. The relative plentiful of the most profoundly found families in euthyroid thyroid cancer and healthy controls. D and C represent euthyroid thyroid cancer and control group, respectively, (C) The genera levels gut bacterial compositions from High-throughput sequencing results. The relative abundance of the most prevalent genera in euthyroid thyroid cancer and healthy control. D and C represent euthyroid thyroid cancer and control group, respectively, (D) LDA (linear discriminant analysis) value distribution histogram was applied to find the most altered gut bacterial taxa abundance between euthyroid thyroid cancer patients D and control subjects C.
Gut microbial taxa at phyla and families level from High-throughput results
| Taxa | Mean D | Mean C | p.value | q value | %D | % C |
|---|---|---|---|---|---|---|
| Phylum | ||||||
| Bacteroidetes | 0.2224 | 0.6605 | 0.0010 | 0.0040 | 22.24 | 66.05 |
| Proteobacteria | 0.2420 | 0.0941 | 0.1039 | 0.1662 | 24.20 | 9.41 |
| Firmicutes | 0.4305 | 0.2345 | 0.0050 | 0.0160 | 43.05 | 23.45 |
| Verrucomicrobia | 0.0862 | 0.0009 | 0.0010 | 0.0040 | 8.62 | 0.09 |
| Actinobacteria | 0.0167 | 0.0092 | 0.2947 | 0.3929 | 1.67 | 0.92 |
| Tenericutes | 0.0015 | 0.0000 | 0.0060 | 0.0160 | 0.15 | 0.00 |
| Fusobacteria | 0.0000 | 0.0008 | 0.0290 | 0.0515 | 0.00 | 0.08 |
| Saccharibacteria | 0.0002 | 0.0000 | 0.0070 | 0.0160 | 0.02 | 0.00 |
| Synergistetes | 0.0001 | 0.0000 | 0.0010 | 0.0040 | 0.01 | 0.00 |
| Cyanobacteria | 0.0002 | 0.0000 | 0.0250 | 0.0500 | 0.02 | 0.00 |
| Others | 0.01 | 0.00 | ||||
| Family | ||||||
| Enterobacteriaceae | 0.2169 | 0.0650 | 0.0679 | 0.2323 | 21.69 | 6.50 |
| Prevotellaceae | 0.0167 | 0.2624 | 0.0030 | 0.0325 | 1.67 | 26.24 |
| Bacteroidaceae | 0.1260 | 0.3238 | 0.0150 | 0.0949 | 12.60 | 32.38 |
| Verrucomicrobiaceae | 0.0862 | 0.0009 | 0.0010 | 0.0127 | 8.62 | 0.09 |
| Ruminococcaceae | 0.2750 | 0.1113 | 0.0050 | 0.0475 | 27.50 | 11.13 |
| Lachnospiraceae | 0.1323 | 0.0889 | 0.1259 | 0.3417 | 13.23 | 8.89 |
| Rikenellaceae | 0.0621 | 0.0378 | 0.2478 | 0.5717 | 6.21 | 3.78 |
| Porphyromonadaceae | 0.0125 | 0.0351 | 0.0070 | 0.0591 | 1.25 | 3.51 |
| Desulfovibrionaceae | 0.0144 | 0.0011 | 0.0010 | 0.0127 | 1.44 | 0.11 |
| Alcaligenaceae | 0.0020 | 0.0237 | 0.0010 | 0.0127 | 0.20 | 2.37 |
| Others | 5.58 | 5.02 | ||||
Euthyroid thyroid cancer D and Control C, P<0.05
Gut microbial phylotypes at genus level from High-throughput results
| Taxa | Mean D | Mean C | p.value | q value | % D | % C |
|---|---|---|---|---|---|---|
| Genus | ||||||
| Escherichia-Shigella | 0.1941 | 0.0265 | 0.0140 | 0.0824 | 19.41 | 2.65 |
| Prevotella_9 | 0.0125 | 0.2568 | 0.0020 | 0.0193 | 1.25 | 25.68 |
| Bacteroides | 0.1260 | 0.3238 | 0.0160 | 0.0869 | 12.60 | 32.38 |
| Akkermansia | 0.0862 | 0.0009 | 0.0010 | 0.0125 | 8.62 | 0.09 |
| Klebsiella | 0.0031 | 0.0351 | 0.0340 | 0.1412 | 0.31 | 3.51 |
| [Eubacterium]_coprostanoligenes | 0.0564 | 0.0178 | 0.0290 | 0.1253 | 5.64 | 1.78 |
| Subdoligranulum | 0.0888 | 0.0105 | 0.0010 | 0.0125 | 8.88 | 1.05 |
| Dorea | 0.0377 | 0.0038 | 0.0010 | 0.0125 | 3.77 | 0.38 |
| Citrobacter | 0.0179 | 0.0020 | 0.4525 | 0.7260 | 1.79 | 0.20 |
| Ruminococcus_2 | 0.0459 | 0.0109 | 0.0180 | 0.0953 | 4.59 | 1.09 |
| Alistipes | 0.0619 | 0.0377 | 0.2388 | 0.4907 | 6.19 | 3.77 |
| Ruminococcaceae_UCG-013 | 0.0280 | 0.0024 | 0.0020 | 0.0193 | 2.8016 | 0.2437 |
| Ruminococcaceae_UCG-002 | 0.0168 | 0.0060 | 0.1948 | 0.4302 | 1.6804 | 0.5981 |
| [Eubacterium]_rectale_group | 0.0181 | 0.0248 | 0.5335 | 0.7440 | 1.8073 | 2.4769 |
| Parabacteroides | 0.0092 | 0.0314 | 0.0080 | 0.0529 | 0.9193 | 3.1430 |
| Faecalibacterium | 0.0137 | 0.0385 | 0.0030 | 0.0254 | 1.3730 | 3.8462 |
| Desulfovibrio | 0.0112 | 0.0004 | 0.0010 | 0.0125 | 1.1250 | 0.0424 |
| Bifidobacterium | 0.0074 | 0.0143 | 0.2358 | 0.4900 | 0.7390 | 1.4255 |
| Ruminococcus_1 | 0.0041 | 0.0082 | 0.5654 | 0.7684 | 0.4091 | 0.8187 |
| Parasutterella | 0.0018 | 0.0203 | 0.0240 | 0.1105 | 0.1752 | 2.0260 |
| Megamonas | 0.0003 | 0.0079 | 0.0010 | 0.0125 | 0.0338 | 0.7905 |
| Dialister | 0.0006 | 0.0061 | 0.0999 | 0.2750 | 0.0586 | 0.6062 |
| Phascolarctobacterium | 0.0021 | 0.0044 | 0.5604 | 0.7665 | 0.2124 | 0.4408 |
| Paraprevotella | 0.0026 | 0.0053 | 0.3516 | 0.6318 | 0.2646 | 0.5263 |
| Ruminococcaceae_NK4A214_group | 0.0051 | 0.0020 | 0.1369 | 0.3297 | 0.5058 | 0.1965 |
| Lachnoclostridium | 0.0052 | 0.0098 | 0.0420 | 0.1435 | 0.5250 | 0.9817 |
| Christensenellaceae_R-7_group | 0.0035 | 0.0009 | 0.1129 | 0.2919 | 0.3494 | 0.0879 |
| Blautia | 0.0081 | 0.0039 | 0.0619 | 0.1960 | 0.8060 | 0.3923 |
| Coprococcus_2 | 0.0012 | 0.0043 | 0.0519 | 0.1721 | 0.1230 | 0.4276 |
| Ruminococcaceae_UCG-014 | 0.0005 | 0.0026 | 0.2238 | 0.4697 | 0.0476 | 0.2559 |
| Others | 12.3011 | 8.7739 | ||||
Euthyroid thyroid cancer D and Control C, (P < 0.05)
High-throughput differential intestinal bacterial phylotypes between euthyroid thyroid cancer D and Control C at the species level
| Taxa | Mean C | Mean D | p value | q value |
|---|---|---|---|---|
| Escherichia coli | 0.026521 | 0.194062 | 0.016983 | 0.079437 |
| Bacteroides vulgatus | 0.166316 | 0.033518 | 0.004995 | 0.03812 |
| Klebsiella_pneumoniae | 0.03508 | 0.003094 | 0.022977 | 0.104115 |
| Dorea longicatena | 0.003479 | 0.035789 | 0.000999 | 0.013169 |
| Bacteroides stercoris | 0.065741 | 0.005255 | 0.001998 | 0.019314 |
| Bacteroides uniformis | 0.028511 | 0.006969 | 0.00999 | 0.060356 |
| Akkermansia muciniphila | 0.000379 | 0.01261 | 0.001998 | 0.019314 |
| Parabacteroides distasonis | 0.018982 | 0.004001 | 0.015984 | 0.079437 |
| Bacteroides cellulosilyticus | 0.004009 | 0.015244 | 0.032967 | 0.119505 |
| Dialistersuccinatiphilus | 0.003622 | 0.000106 | 0.042957 | 0.144855 |
| Bacteroides coprophilus; | 0.0039 | 0.000248 | 0.008991 | 0.059259 |
| Bacteroides plebeius | 0.006049 | 0.000388 | 0.002997 | 0.025563 |
| Bacteroides massiliensis | 0.006224 | 0.000758 | 0.002997 | 0.025563 |
| Roseburia inulinivorans; | 0.010472 | 0.002868 | 0.001998 | 0.019314 |
| Bacteroides thetaiotaomicron; | 0.007045 | 0.002454 | 0.026973 | 0.111745 |
| Subdoligranulum_sp._4_3_54A2FAA | 0.00044 | 0.002646 | 0.001998 | 0.019314 |
| Lactobacillus mucosae | 0.000586 | 1.87E-05 | 0.030969 | 0.115141 |
| Bacteroides salyersiae | 0.000504 | 3.17E-05 | 0.015984 | 0.079437 |
| Fusobacterium varium; | 0.00078 | 2.43E-05 | 0.030969 | 0.115141 |
| Bacteroides eggerthii | 0.000621 | 8.40E-05 | 0.02997 | 0.115141 |
| Dorea formicigenerans | 0.000351 | 0.001935 | 0.000999 | 0.013169 |
| [Clostridium] leptum | 6.91E-05 | 0.000674 | 0.090439 | 0.113169 |
| Faecalibacterium_prausnitzii | 7.09E-05 | 0.001133 | 0.00999 | 0.013169 |
| Lactobacillusruminis | 0.000215 | 1.87E-06 | 0.011988 | 0.06953 |
| Ruminococcus_sp._16442; | 1.49E-05 | 0.000155 | 0.023976 | 0.105349 |
| [Clostridium] scindens | 0.000101 | 0.000317 | 0.030969 | 0.115141 |
| Paraprevotella xylaniphila; | 0.000106 | 3.73E-06 | 0.016983 | 0.079437 |
| Pseudomonas caeni | 0.000105 | 3.73E-06 | 0.008991 | 0.059259 |
| Pyramidobacter piscolens | 0 | 9.52E-05 | 0.000999 | 0.013169 |
| Acinetobacter_lwoffii | 3.73E-06 | 8.21E-05 | 0.026973 | 0.111745 |
P<0.05.